Choi Bean, Glávits Róbert, Murbach Timothy S, Endres John R, Hirka Gábor, Szakonyiné Ilona Pasics
AIBMR Life Sciences, Inc., Seattle, Washington, USA.
Toxi-Coop Zrt., Budapest, Hungary.
J Appl Toxicol. 2024 Nov;44(11):1816-1830. doi: 10.1002/jat.4663. Epub 2024 Aug 4.
Xanthobacter sp. SoF1 (SoF1) is an autotrophic hydrogen-oxidizing bacteria that produces protein-rich biomass and has potential to be an alternative protein source that is more environmentally sustainable than animal and plant derived proteins. A protein-rich powder derived from SoF1 was the test material in a 90-day repeated-dose oral toxicity study to explore major toxic effects, demonstrate target organs, and provide an estimate of a no-observed-adverse-effect level (NOAEL). Daily doses of 0 (vehicle only), 375, 750, and 1500 mg/kg bw/day of the test material were administered by gavage to 10 Han:WIST rats/sex/group. An additional group was administered 1290 mg/kg bw/day whey protein concentrate as positive control. No treatment-related adverse effects were observed, and no target organs were determined after 90/91 days of consecutive administration of the test item. A NOAEL of 1500 mg/kg bw/day was determined.
黄色杆菌属SoF1(SoF1)是一种自养型氢氧化细菌,能产生富含蛋白质的生物质,有潜力成为一种比动物和植物源蛋白质更具环境可持续性的替代蛋白质来源。一种源自SoF1的富含蛋白质的粉末是一项为期90天的重复剂量口服毒性研究中的受试材料,该研究旨在探索主要毒性作用、确定靶器官,并估算未观察到不良反应的剂量水平(NOAEL)。通过灌胃法,将受试材料以每日0(仅赋形剂)、375、750和1500 mg/kg体重/天 的剂量分别给予10只/性别/组的Han:WIST大鼠。另外一组给予1290 mg/kg体重/天的乳清蛋白浓缩物作为阳性对照。连续给药90/91天后,未观察到与治疗相关的不良反应,也未确定靶器官。确定的NOAEL为1500 mg/kg体重/天。